Funding news
Owl Labs logo

Owl Labs Secures $25M Series

Recently funded · $25.0M Series cTechnology, Information and MediaUS

Get the full Owl Labs company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Owl Labs has raised $25.0 million in new investment capital from investors. The company is recognized for revolutionizing the way the world works, primarily through its innovative and award-winning Meeting Owl product line. This significant funding round underscores investor confidence in Owl Labs' vision and its established position in the evolving landscape of hybrid work solutions.

The Meeting Owl, a flagship product, is designed to enhance collaboration and inclusivity in meetings, particularly for remote and hybrid teams. Its technology aims to create more equitable meeting experiences, ensuring all participants, regardless of their location, can engage effectively. This latest capital infusion will enable Owl Labs to further its mission of developing tools that address the complexities of modern work environments.

Owl Labs plans to strategically deploy the $25.0 million to accelerate its growth initiatives. This includes investing in research and development to enhance its existing product offerings and explore new technological advancements. The company also intends to expand its market reach, bringing its solutions to a broader global audience, and scale its operational capabilities to meet increasing demand.

This funding round is a pivotal moment for Owl Labs as it continues to innovate within the hybrid work sector. The capital secured will support the company's efforts to strengthen its market leadership and continue delivering solutions that empower organizations to adapt to flexible work models. Owl Labs remains committed to its long-term vision of shaping the future of work through continuous innovation and strategic expansion.

Other United States companies recently funded

View all

Other recent Series c rounds

Companies that recently closed a Series c round.

#CompanyAmount
1
Butterfly Medical logo

Butterfly Medical

Israel

$21.0M
2
Yabie logo

Yabie

Sweden

$26.2M
3
Trevi Therapeutics, Inc. logo

Trevi Therapeutics, Inc.

United States

$50.5M
4
Freyja Healthcare logo

Freyja Healthcare

$20.5M
5
NuCurrent logo

NuCurrent

United States

$100.0K